ロング

STEM. Is it too early? or just the right time.

103
Trade idea. Choppy. Pay close attention to RSI and MAC D histo. Price targets in blue upon validation.

First Half 2014: Initiate Phase II efficacy trial in spinal cord treatment

2014: Initiate Phase II efficacy trial in AMD

2015: Interim results of proof of concept trials on both AMD and spinal cord injuries

2016: The company plans to file an IND for the safety and efficacy of HuCNS-SC cells to restore memory loss in Alzheimer's patients.

免責事項

この情報および投稿は、TradingViewが提供または推奨する金融、投資、トレード、その他のアドバイスや推奨を意図するものではなく、それらを構成するものでもありません。詳細は利用規約をご覧ください。